SUMO1 levels are reduced in the PTSD patients, demonstrating impaired stress response pathways, while MDA, CX3CL1, and UCHL1 levels are elevated, indicating heightened oxidative stress, neuroinflammation, and neuronal stress responses, respectively. The gene discussed is SUMO1; the disease is post-traumatic stress disorder.